Skip to main content
American Pain Society
Menu
Login
Search
  • Membership
    • Membership Overview
    • Membership Categories
    • Member Spotlight
      • Spotlight – Salimah Meghani
      • Spotlight – Adam Hirsh
      • Spotlight – Deb Gordon
      • Member Spotlight Archive
      • Spotlight – Arian Nachat, MD FABEM FABHPM
      • Spotlight – Benedict J. Kolber, PhD
      • Spotlight – Beth Darnall, PhD
      • Spotlight – Gonzalo Flores, LAc MAcOM
      • Spotlight – Gregory Terman, MD PhD
      • Spotlight – J. Bruce Hillenberg, PhD ABPP
      • Spotlight – Jeffrey Mogil, PhD
      • Spotlight – Neil Singla, MD
      • Spotlight – S. Stevens Negus, PhD
      • Spotlight – Sean Ustic, PharmD
      • Spotlight – Story Landis, PhD
      • Spotlight – Darnall 2
      • Spotlight – Anna Wilson
      • Spotlight – Seena Ajit
      • Spotlight – Marie Bement
      • Spotlight – Peter Grace
      • Spotlight – David Thomas
    • Member Demographics
    • Recruit
    • Join/Renew
    • Membership Directory
    • January 2019 New Members
    • February 2019 New Members
  • Meetings and Events
    • 2019 Scientific Meeting
      • 2019 Scientific Meeting
        • 2019 Speaker Media Kit
        • Scientific Meeting: Science Landing Page
        • Scientific Meeting: Clinical Landing Page
        • Refer a colleague
        • Social Media Champion
        • 2019 Social Media Champions
        • Registration Rates
        • Hotel and Travel
        • 2019 Meeting Prospects
          • Thank You
        • Schedule
        • Continuing Education
        • 2019 Speaker Highlight
        • 2019 SIG Schedule
        • Accepted Posters
        • Spring Pain
        • Fundamentals Course
        • Conference on Analgesic Trials
        • Early Career Forum
        • Data Blitz
        • Exhibits and Support
        • Sponsorship Opportunities
        • Early Career Forum Mentors
        • 2019 Young Investigator Recipients
        • Scientific Program Committee
        • 2019 App Tips
    • 32nd Annual Scientific Meeting Evaluation
    • 2017 Call for Poster Abstracts
    • Past Meetings
      • Abstract Database
    • Email Landing Page 2017
    • 2018 Scientific Summit Poster Presenters in the Media
  • Education
    • Guidelines
      • Guideline for the Management of Acute and Chronic Pain in Sickle-Cell Disease
      • Archived Guidelines
    • The Journal of Pain
      • Journal of Pain iPad App
    • Journal Summaries
      • JOP July 2018 – 1
      • JOP July 2018 – 2
      • Clinical JOP July 2018 – 1
      • Clinical JOP July 2018 – 2
      • PAIN July 2018 – 1
      • PAIN July 2018 – 2
      • JOP August 2018 – 1
      • JOP August 2018 – 2
      • Clinical JOP August 2018 – 1
      • Clinical JOP August 2018 – 2
      • PAIN August 2018 – 1
      • PAIN August 2018 – 2
      • JOP September 2018 – 1
      • JOP September 2018 – 2
      • JOP October 2018 – 1
      • JOP October 2018 – 2
      • JOP November 2018 – 1
      • JOP November 2018 – 2
      • JOP December 2018 – 1
      • JOP December 2018 – 2
      • JOP January 2019 – 1
      • JOP January 2019 – 2
      • JOP February 2019 – 1
      • JOP February 2019 – 2
      • JOP March 2019 – 1
      • JOP March 2019 – 2
    • Principles of Analgesic Use
    • APS E-News
      • E-News Archives
      • Member Stories
    • Online Education Programs
    • Training in Pain and Associated Symptoms Research – Nursing
    • The Methadone Safety Guidelines: A Live Webinar
    • 2010 Revised Questionnaire
    • Events Calendar
    • CE Mission Statement
    • Webinars
    • Resources
      • Resource – Fibromyalgia
      • Resources – Sickle Cell Disease
      • Chronic Low Back Pain
    • Clinical Centers Guide
    • Military/Veterans SIG Meeting
    • Psychosocial Research SIG Meeting
    • Primary Care SIG Meeting
    • Pain and Disparities SIG Meeting
    • Ethics/Pain Rehabilitation SIG Meeting
    • Plenary Lecture: The Biology of Infant and Childhood Pain: It All Begins Here
    • Kerr Lecture: Distributed Processing of Pain: From the Spinal Cord to the Brain
    • Fordyce Lecture: Simplifying Evidence-Based Pain Self-Management Therapies for Chronic Pain: Rationale, Efficacy, and Implementation
    • Plenary Lecture: In Pursuir of More Powerful Non-Pharmacologic Treatments for Musculoskeletal Pain with Centralized Features
    • Plenary Lecture: Taking Aim is Easier When You Know the Target: Moving Toward Mechanism-Based Pain Assessment
    • Plenary Lecture: Assessment and Management of Neuropathic Pain: Advances, Challenges, and Opportunities
    • Plenary Lecture: Spinal Mechanisms of Spinal Cord Injury-Induced Neuropathic Pain: Implications for Novel Therapeutic Targets
    • Plenary Lecture: Variability in the Pain Experience after Injury
    • Neurobiological Mechanisms Supporting Integrative and Mind-Body Therapies for Pain
    • Bottom-up vs. Top-down: The Search for Effective Mechanisms in Psychosocial Treatments for Chronic Pain
    • Novel Mechanisms Underlying Risk for Acute and Chronic Post-Surgical Pain: Role of Peripheral Pain Processing, Central Sensitization, and Genomics
    • Psychology Treatments for Chronic Pain: Who Benefits & Why?
    • Descending Modulation of Pain and the Endocannabinoid System: Sites, Mechanisms, and Therapeutic Potential
    • Muscle Pain Mechanisms: It’s Time to Dive Deep
    • Mechanism-Based Approach to Clinical Trial Design in Chemotherapy-Induced Peripheral Neuropathy
    • At the Intersection of Affect Regulation, Reward/Value Process, and Placebo: Altered Human Psychological, Neurobiological, and Opioidergic Systems in Chronic Pain
    • Putting the Spotlight on Social: An Innovative Multidisciplinary, Multi-Species Approach for Examining the Influence of Social Context in Pain
    • Migraine and Sleep Deficiency in Adolescents: Understanding Shared Mechanisms for Bench to Bedside
    • Novel Directions in Basic Science Research: Rita Allen Scholars
    • Exploiting Cellular and Molecular Mechanisms of Neuroinflammation for New Treatments of Chronic Pain
  • Funding Opportunities
    • Grants
      • Where Are Future Leaders Now?
      • Future Leaders
        • 2009-fl-laura-simons
        • Barbara Hastie
        • Robert Edwards
        • Susan Dorsey
        • Beth Darnall
        • Jill Fehrenbacher
        • Ted Price
        • Anna Long
        • Jamie Rhudy
        • Laura Frey Law
        • Lisa Loram
        • Magali Millecamps
        • Edgar Romero-Sandoval
        • Gregory Dussor
        • Khara Ramos
        • Lynnae Schwartz
        • Michelle Fortier
        • Christopher King
        • Jennifer Lee
        • Kimberly Sibille
        • Shivani Ruparel
        • Steve Davidson
        • Claudia Campbell
        • Jennifer DeBerry
        • Tim Doyle
        • Adam T. Hirsh, PhD
        • David A. Seminowicz, PhD
        • Ohannes K. Melemedjian, PhD
        • Burel R. Goodin, PhD
        • 2014 Future Leaders in Pain Research Recipients
        • Future Leaders – Past Recipients
      • Sharon S. Keller Chronic Pain Research Grant
        • Sharon S. Keller Grant Past Recipients
      • Future Leader Spotlight – Copits
      • Future Leader Spotlight – Janevic
      • Future Leader Spotlight – Jarrahi
    • APS and Pfizer IGLC
    • METER Mayday Award
    • Pfizer IGLC for Pain Research
  • Get Involved
    • 2019 Call for Nominations
    • Awards & Grants
      • Clinical Centers of Excellence in Pain Management
        • CCOE Recipients
        • 2009 Clinical Centers of Excellence in Pain Management Award – Special Commendation
          • John C. Liebeskind Early Career Scholar Award
            • David A. Seminowicz, PhD
            • Laura E. Simons, PhD
            • Claudia M. Campbell, PhD
        • 2014 Clinical Centers of Excellence Award Recipients
        • 2013 CCOE Recipients
        • 2012 CCOE Recipients
        • 2012 CCOE Ceremony
        • 2010 CCOE Special Commendations
        • 2011 CCOE Recipients
        • 2010 CCOE Recipients
        • CCOE Applications
        • CCOE Past Recipients
      • Distinguished Service Award
        • Edward Michna, JD MD
        • Charles E. Inturrisi, PhD
        • David A. Williams, PhD
      • Elizabeth Narcessian Award for Outstanding Educational Achievements in the Field of Pain
        • Penney Cowan
        • Joanna Girard Katzman, MD MSPH
        • Charles Argoff, MD
      • Kathleen M. Foley Journalist Award
        • Rita Rubin
        • Michelle Andrews
        • Judy Foreman
      • Jeffrey Lawson Award for Advocacy in Children’s Pain Relief
        • Elliot Krane
        • Carlton Dampier, MD
        • Anna Tadio
      • John and Emma Bonica Public Service Award
        • Ann O’Mara
        • Phillip A. Pizzo, MD
        • Dennis C. Turk, PhD
        • Robert H. Dworkin
      • Rita Allen Foundation Award in Pain
        • Rita Allen Foundation Award Recipients
      • Wilbert E. Fordyce Clinical Investigator Award
        • Jennifer Haythornthwaite, PhD
        • William Maixner
        • Mark P. Jensen, PhD
      • Frederick W.L. Kerr Basic Science Research Award
        • Kathleen Sluka, PT PhD
        • Jeffrey S. Mogul, PhD
        • Michael J. Iadarola, PhD
      • 2015 CCOE Recipients
      • 2015 Distinguished Service Award – Savage
      • 2015 Foley Award – Thernstrom
      • 2015 Bonica Service Award – Rappaport
      • 2015 Fordyce Award – Clauw
      • 2015 Kerr Basic Science Award – Woolf
      • 2015 Jeffrey Lawson Award – Johnston
      • 2015 Liebeskind Award – Hirsh
      • 2015 Narcessian Award – Fishman
      • 2016 Award Nominations
      • 2016 Narcessian Award – Friedrichsdorf
      • 2016 Lawson Award – Chambers
      • 2016 Liebeskind – Trost
      • 2016 Bonica Award – Christo
      • 2016 CCOE Award Recipients
      • 2016 Fordyce Award – Mackey
      • 2016 Kerr Award – Gold
      • 2016 Foley Award – Peachman
      • Brewer Distinguished Teaching of Psychology Award
      • 2017 Distinguished Service Award – Fillingim
      • 2017 Narcessian Award – Kitlinski
      • 2017 Kerr Award – Gereau
      • 2017 Lawson Award – von Baeyer
      • 2017 Bonica Award – Porter
      • 2017 Liebeskind Award – Goodin
      • 2017 Fordyce Award – Kerns
      • 2018 Distinguished Service – Herndon
      • 2018 Narcessian – Gallagher
      • 2018 Kerr – Coghill
      • 2018 Lawson – Grunau
      • 2018 Bonica – Moseley
      • 2018 Liebeskind – Merlin
      • 2018 Fordyce Award – BThorn
      • 2018 Kerr Award – RCoghill
      • 2018 Bonica Award – LMoseley
      • 2018 Lawson Award – RGrunau
      • 2018 Liebeskind Award – JMerlin
      • 2018 Narcessian Award – RGallagher
      • 2019 Liebeskind Award – Noel
      • 2019 Bonica Award – Thomas
      • 2019 Kerr Award – Pasternak
      • 2019 Distinguished Award – Walco
      • 2019 Narcessian Award – Mogil
      • 2019 Fordyce Award – Tait
      • 2019 Lawson Award – Riddell
    • Special Interest Groups
      • Advancing the Science of Quality
      • Clinical Trials
        • APS-CAT Webinar
      • Ethics
      • Genetics and Pain
      • Geriatric Pain
      • Measurement of Pain and Its Impact
      • Nursing
      • Pain Education
      • Pain in Sickle Cell Disease
      • Pain Rehabilitation
      • Palliative Care
      • Primary Care
      • Psychosocial Research
      • Basic Science
      • Pain and Disparities
      • Pharmacotherapy
      • Pain in Infants, Children, and Adolescents
      • Complementary and Alternative Medicine
      • Military/Veterans SIG
      • Basic Science SIG – Election
      • Headache SIG
      • Sex & Gender in Pain and Analgesia
      • SIG Election – Psychosocial
      • SIG Election – Basic Science
      • SIG Election – Pediatric
    • Regional Societies
      • Southern Pain Society
        • Organization and Membership
        • Officers and Board Members
      • Midwest Pain Society
        • Board and Officers
        • MPS Mission Statement
        • Meeting Workshop Handouts
      • Eastern Pain Association
        • Why Join?
        • EPA Mission Statement
      • Western Pain Society
      • Greater Philadelphia Pain Society
    • Commercial Support
    • Advocacy
      • Pain Care Coalition
      • Pain Care Coalition Timeline
      • 2016 National Pain Strategy Presentation
      • July 2018 Advocacy FDA
      • July 2018 Advocacy NIH
      • July 2018 Advocacy NIH HEAL
    • Pain Research Fund
      • PRF Donors
      • PRF FAQ
    • 2016 Distinguished Service Award – Haythornthwaite
    • Early Career Resources
      • Early Career Advisory Group Members
      • Early Career Job Board
      • Training and Career Development Applicant Resources
    • ECAG Application
    • ECAG Vice Chair Nomination
    • Call for Volunteers
    • ECAG Poster Tips
      • Who’s Who in APS
        • Board of Directors
        • Committee and Special Interest Group Chairs
        • APS Staff
        • Organizational Structure
        • Strategic Plan
        • APS Bylaws
        • History of APS
        • Position Statements
          • Statement on Research, Funding, and Opioids
          • Society Blog View
        • Code of Ethics
        • Conflict of Interest Policy
          • Financial Conflict of Interest Policy
        • Pain Research Agenda
        • IASP
        • Newsroom
          • American Pain Society’s Annual Scientific Meeting Convenes in New Orleans, May 8-11
          • Adolescent Chronic Pain Costs $19.5 Billion a Year in the United States
          • New Method Helps Doctors Check Pain Drug Compliance
          • New Study Assesses Benefits of Cognitive Pain Relief Methods
          • Pain Intensity Can Predict Head and Neck Cancer Survival
          • Study Estimates Persistent Pain Incidence at 19% of U.S. Adults
          • Study Examines How Doctors Use Prescription Drug Monitoring Programs
          • Low-Dose Vaporized Cannabis Improves Neuropathic Pain
          • American Pain Society Releases Pain Research Agenda for the 21st Century
          • About Newsroom
          • American Pain Society and Journal of Family Practice To Co-sponsor Pain Care Conference for Primary Care Physicians
          • American Pain Society Announces $150,000 Pain Research Grant Program
          • American Pain Society Establishes Private Pain Research Fund
          • American Pain Society Executive Selected as Mayday Fellow
          • American Pain Society Hosting Two Symposia at PAINWeek
          • American Pain Society Presents 2012 Achievement Awards
          • American Pain Society Presents 2013 Achievement Awards
          • American Pain Society Presents 2014 Achievement Award
          • American Pain Society Publishes New Clinical Practice Guideline on Methadone Safety
          • American Pain Society To Provide Grant Support for Pain Research Forum’s “Papers of the Week”
          • Anxiety and Pain Fear Before Surgery Predict Chronic Post-surgical Pain
          • Archived News Releases
          • Cannabinoid Shown Effective as Adjuvant Analgesic for Cancer Pain
          • Drug Treatments for Heroin Addiction Heighten Pain Sensitivity
          • Genetic Alteration Predicts Pain Recovery After Sexual Assault
          • Health Care Reforms Will Change How Pain Is Assessed and Treated
          • High-dose Opioid Treatment Associated with Mental Health and Medical Comorbidities
          • Inadequate Pain Research Funding Hampers Effort to Find Safer and More Effective Treatments
          • Injury Fears Can Predict Impairment in Low Back Pain Patients
          • Internalized Stigma Linked with Poor Self Esteem and Pain Self-Efficacy
          • Motives Assessed for Opioid Misuse Among Adolescents
          • Negative Physician Attitudes About Opioid Pain Meds Linked with Lower Prescribing
          • New SmartPhone Apps Help Doctors Manage Pain Patients
          • No Relief Yet for Brutal Oral Cancer Pain, but Cannabinoids May Offer Some Hope
          • One-fourth of Breast Cancer Surgery Patients Have Persistent Pain
          • Pain Research Funding Inadequate in the Face of Soaring Incidence and Treatment Costs
          • Pain Research Yielding Encouraging Discoveries, But Funding Cuts Threaten Future Advances
          • Positive Activities Administered Online Help in Pain Management
          • Primary Care Doctors Prefer NSAIDS for Chronic Pain Treatment
          • REMS Statement
          • Risk Factor Management Helps Prevent Migraine Attacks
          • Sedatives and Alcohol Increase Risk for Pain Medication Adverse Events
          • Study Shows Pain Drug Craving Occurs With or Without Risk for Misuse
          • Severe Pain in Sexual Assault Survivors Often Not Treated
          • Severity of Acute Low Back Pain Predicts Development of Chronic Pain
          • Spinal Manipulative Therapy Lessens Central Pain Sensitization
          • Study Assesses Differences in Physician and Patient Pain Assessments
          • Study Assesses Mood Disorders with TMJ Pain
          • Study Assesses Pain and Quality of Life in Ugandan HIV Patients
          • Study Assesses Role of Caregiver Anxiety on Children’s Pain
          • Study Examines Treatment Responses in TMD Patients
          • Study Explores Role of Impaired Sleep in Fibromyalgia Pain
          • Study Evaluates Frequency of Pediatric Pain Assessments
          • Study Links Pre-operative Breast Cancer Pain to Inflammatory Mechanisms
          • Study Shows Pain Coping Success with Acceptance and Commitment Therapy
          • Study shows Physiological Markers for Neonate Pain
          • Study Shows Predictors of Functional Change in Older Women with Recurrent Pain
          • The American Pain Society Presents Full-Day Program at PAINWeek 2012
          • Training the Brain Could Help Reduce Pain
          • University of Florida Psychologist Roger Fillingim, PhD, Becomes President of the American Pain Society
          • University of Washington Anesthesiologist Gregory W. Terman, MD PhD Becomes President of the American Pain Society
          • Yoga Shown Effective for Treating Chronic Neck Pain
          • Study Shows Links of Childhood Pain to Adult Chronic Pain and Fibromyalgia
          • Newsroom Press Releases
            • APS Endorses NPS
            • Study Shows Tai Chi Can Help Relieve Chronic Neck Pain
            • Post-surgical Pain Management Can Influence Progression to Chronic Pain
            • American Pain Society Presents 2017 Achievement Awards
            • American Pain Society Encouraged by Pain Research Funding Progress
            • American Pain Society Scientific Meeting, April 3-6, Milwaukee
            • langevin-plenary
            • moron-concepcion-plenary
            • koroshetz-plenary
          • Newsroom 2013 News Releases
          • Newsroom 2014 News Releases
          • Press Room – Pain Education in Physical Therapy Schools
          • Press Room – Misuse of Therapeutic Opioids
          • Press Room – Meditation Can Reduce Chronic Neck Pain
          • Press Room – Link of Preexisting Mental Disorders
          • APS Scientific Meeting in Palm Springs
          • Nerve Involvement Explains Why Some Cancers are Very Painful
          • American Pain Society Presents 2014 Achievement Awards
          • American Pain Society Honors Clinical Centers of Excellence in Pain Management Award Recipients
          • Strong Evidence Still Lacking on Medical Marijuana for Pain
          • Fibromyalgia Has Central Nervous System Origins
          • Yoga and Chronic Pain Have Opposite Effects on Brain Gray Matter
          • Newsroom 2015 Releases
          • Patient-Centered Outcomes Studies Needed in Pain Management
          • Improving Sleep Quality Has Pain Control Benefits
          • Use of Multiple Pharmacies Can Predict Opioid Overdosing
          • Inhaled Cannabis Shown Effective for Diabetic Neuropathy Pain
          • NIH Study Shows Prevalence of Chronic or Severe Pain in U.S. Adults
          • Physical Therapy for Carpal Tunnel Syndrome Pain Often As Effective as Surgery
          • Mental Disorders Increase Risk for Eventual Chronic Pain in Adolescents
          • Study Assesses Long-term Impact of Post-surgical Pain in Children
          • Newsroom 2016 News Releases
            • American Pain Society Publishes Clinical Practice Guideline for Post-surgical Pain Management
          • Study Assesses Impact of Opioid Risk Reduction Initiatives
          • American Pain Society Annual Scientific Meeting, Austin, May 11-14
          • Message CDC Guidelines
          • APS and Pfizer Grant Fund
          • Better Self Management Improves Outcomes for Chronic Pain Care
          • Politics of Pain Epitomizes U.S. Liberal-Conservative Divide
          • Psychological Flexibility Might Be the Key to Better Cognitive-Behavioral Interventions
          • APS Presents 2016 Achievement Awards
          • APS Honors Clinical Centers of Excellence in Pain Management Award Recipients
          • Evidence Shows Benefits of Psychological Care in Pain Management
          • American Pain Society Awarded Research Grant from Mayday Fund
          • American Pain Society Offers Guidance on Medical Marijuana for Pain
          • Study Shows Pain Often Improves in Older Veterans
          • Study showsDistress Intolerance Associated with Opioid Misuse
          • Brain Stimulation Technique Shown Effective in Phantom Limb Pain
          • Early Childhood Pain Can Predict Chronic Pain in Adolescence
          • American Pain Society Urges Congress to Oppose Steep Budget Cuts for National Institutes of Health
          • Newsroom 2017 News Releases
          • Holistic, Patient Centered Care Gaining Acceptance for Pain Management
          • Wearable Devices Communicate Vital Brain Activity Information
          • Practical Clinical Trials Can Help Find Alternatives to Opioids
          • Better Self-Management Improving VA Outcomes for Chronic Pain Care
          • Study Links Sleep Patterns with Pain Persistence After Pediatric Surgery
          • Study Shows Cognitive Behavioral Therapy Improves Functioning for People with Chronic Pain
          • American Pain Society’s 2018 Annual Meeting Features New, Single-theme Format
          • Pain Severity Leading Predictor of Prolonged Opioid Use After Surgery
          • American Pain Society Supports Passage of Marijuana Effective Studies Act
          • American Pain Society Selects Future Leaders in Pain Research Grant Recipients
          • Study Shows High Rate of Chronic Pain in Homeless Older Adults
          • Study Explores Patient-Doctor Communication About Opioid Tapering
          • American Pain Society Scientific Summit Explores Pain Mechanisms
          • American Pain Society’s 2018 Annual Meeting Explores Pain Mechanisms
          • Sleep Improves Pain and Post Traumatic Stress Disorder Symptoms in Youth
          • Effective Pain Assessments Achieved by Targeting Multiple Pain Mechanisms
          • Post-surgery Pain Resolution Mechanisms Can Explain Healing Variability
          • Babies Feel Pain Even if They’re Not Crying
          • Literacy Deficiencies Restrict Access to Cognitive-Behavioral Pain Therapy
          • American Pain Society Endorses NIH Initiative to Curb Opioid Addiction
          • William Maixner, DDS, PhD Elected American Pain Society President
          • American Pain Society Endorses Compromise Marijuana Studies Act
          • Improved Access to Alternative Care Is Best Option to Curb Opioid Misuse
          • Newsroom 2018 News Releases
          • Pain Rehab Programs without Opioids Proving Effective
          • American Pain Society Selects Tonya Palermo, PhD Treasurer and Three New Directors
          • Online Acceptance and Commitment Therapy Effective for Fibromyalgia
          • Newsroom 2019 News Releases
        • Privacy Policy
        • Contact Us
        • Annual Reports
        • Career Center
        • 2016 Bylaws Proposed Changes
        • Call for Volunteers
        • APS News
          • General Blog View
            • APS Guidelines Set High Standard of Excellence
            • Funding Announcement
            • Member Benefit: The Power of Collaboration
            • Pain Research Agenda for the 21st Century
            • Register Now
            • 2015 Keller Grant Recipients
            • Clinical Trial Studies Effectiveness of Jyoti Meditation
            • Chiropractic Physicians Urge Conservative Approach to Pain Management
            • Closing the Sex Gap in Preclinical Pain Research
          • 2019 Plenary Biographies
            • Health & Wellness
  • Pain Care Outcomes Unaffected by Opioid Dose Reductions
    • Board – Resources
    • Board – Meetings
    • Board – Reporting
      • Board – Minutes
  • Health News

Best Dianabol (Dbol) Pills 2025: For Sale, Dianabol Cycle and Dosage | Dbol Before and After Results?

Dianabol D-bal Pills

Dianabol (D-Bol) Pills Explained: The OG Mass Builder, Risks, Benefits & Side Effects Read Before Use?

A steroid that never loses its grip on the bodybuilding community is Dianabol, aka Dbol. The anabolic substance encompasses a glorified history as celebrities like Arnold Schwarzenegger publicly admitted using Dbol pills for bigger gains.

Dianabol is one of the most dependable steroids in history offering incredible promise to mass gainers and athletes. The anabolic steroid primarily works to jack up muscle gains and build dramatic strength in a record time.

How often do we relate anabolic steroids to fitness enthusiasts and sportsmen in general? Indeed, more often than not!

This is because these substances have been contributing to their muscle-building and fat-loss goals for not just years but decades.

Yes, anabolic steroids appear to be some bodybuilders’ go-to. Due to their testosterone-related properties, these artificial steroid hormones are common inclusions in fitness regimens.

Through this write-up, let’s learn the nitty-gritty of the Dbol steroid, covering areas like its dosages and results. By the end, you may probably learn about the hype surrounding Dianabol and the potential dangers it carries.

DIANABOLSTEROID

Dianabol is the brand name of methandienone, whose claim to fame is a boost in muscular growth and strength. Belonging to the class of androgenic anabolic steroids, Dbol is the most budget-friendly and valuable inclusion in bulking cycles.

In general, the steroid is available in orally active pills that work to enhance the growth of proteins. It also aids in increasing some key amino acids that support the muscle regeneration process, useful for muscle growth.

Now, unlike the many types of steroids in the performance-enhancing drug market, Dianabol is not only popular for muscle growth. As it also contributes to fat loss and the accumulation of energy in the form of glycogen, it is equally found in the good books of general dieters and athletes.

Yes, Dianabol equally serves as a performance booster and fat burner, which is reasonable given its versatile nature.

IS DIANABOL LEGAL?

D-bol is the creation of CIBA Pharmaceuticals. After entering the market in 1955, it made the most noise in the bodybuilding community due to aggressive marketing.

Essentially, Dianabol came across as a substance that was heavily contributing to the key goals of bodybuilders. And so, this spark in its popularity was justifiable on several grounds.

As of today, Dbol is no longer promoted or encouraged for recreational purposes, including physique or performance enhancement. This is because of its tendency to generate androgenic and anabolic complications, the worst of which is liver damage.

Yes, as soon as its negative aspects came to light, the Food and Drug Administration came into action, causing a ban on Dbol.

The US and UK treat it as a controlled drug, except for some countries like Mexico, which sell Dianabol over the counter.

Despite its legal landscape and potential to induce side effects, nothing has undone its appeal in bodybuilding to date.

DIANABOL CYCLE

As per bodybuilding experts, a Dbolcycle may be extremely potent and effective, but it can be harsh on beginners. It may jeopardize the health of the liver while raising the cholesterol levels.

Hence, they can rather kick-start their journey with testosterone for a safer experience first.

If not, they need to be extra responsible with the concentration and dosing criteria.Through that, these beginners can pack on somewhere around 30 pounds in their first Dianabol cycle.

There will be massive improvements in strength encompassing 50+ pounds on compound lifts through the steroid.

  • Beginners: To ensure safety and the utmost effectiveness, a standard cycle should continue for a 5 week span and not more. During the first 2 weeks, they can consume 10 mg/ day and switch to 15 mg for the next 2. In the last week, they can take a slightly higher dose of 20 mg a day
  • Mid-level: Mid-level fitness freaks belong to the category with a former experience with Dianabol. Experts believe that these individuals are more tolerant to Dbol as compared to beginners. And so, can follow a six week cycle starting with a 20 mg dose a day for 2 weeks. For the remaining 4 weeks, however, they can dose at 25 mg a day
  • Pros and advanced: As a pro with the experience of many steroid cycles “under your belt”, you follow a longer Dbol cycle. It can be of 8 weeks, starting with 50 mg a day and increasing the strength with time

Overall, Dianabol can give you serious gains in areas like muscle growth and strength. It holds the power to activate and pace up the metabolism, which indicates its properties to burn fat as well.

However, it is more of a muscle booster that bodybuilders and mass gainers resort to for their bulking cycles.

DIANABOL CYCLE DOSAGE

The standard cycle of Dianabolsteroids is 4 to 6 weeks. Yet, expert-level enthusiasts can extend the duration to a maximum of 8 weeks. During this course, amateurs can follow a dianabol cycle dosage of 10 mg a day.

They can go up to 20 mg a day by the end of the course. A dosage higher than this can cause a serious strain on the liver, so they should strictly avoid it.

Alternatively, mid-levels can begin with a higher strength, say 20 mg a day, and go up to 25 mg a day. Since the bodies of experts are familiar with steroids, they are likely to tolerate more and for a longer time.

Hence, their dosing criteria are not as strict, with 50 mg a day and more by the end.

Overall, Dianabol entails a high anabolic index that gives the steroid its unbeatable muscle-building powers. However, bear in mind that no limitations in terms of duration or strength can prevent Dianabol from generating side effects.

The substance can cause hormonal imbalance, depression, jaundice, and more serious complications such as stroke and heart attack.

DIANABOL CYCLE BEFORE AND AFTER

Let’s put this straight: Dbol pills give you a serious transformation and the level of bodybuilding aesthetic you desire. If we overlook its flip side for a moment and exclusively focus on Dianabol results, we will agree that it is, in fact, a promising substance for bulking progress.

Individuals that follow the Dianabol cycle claim to gain some 30–35 lbs. of weight in a 6-week cycle. However, considering the aromatase enzyme, some of this weight could be from water retention.

Moreover, as it enhances free testosterone and glycogenesis, the improvements you experience in your physical strength and power are also exemplary. This surge in stamina can greatly support your sports performance as well as the aggression you need in your training.

As per user reviews, the steroid also eliminates subcutaneous fat as part of its overall recomposition effect. If we delve into its mechanism to learn how a potent muscle booster like Dbol can equally facilitate fat loss, we will reach two conclusions.

Number one, it boosts protein synthesis, which influences the pace of metabolism. Furthermore, because Dianabol is an exogenous testosterone, it can act as a fat-burning hormone for you!

DIANABOL RESULTS AFTER 2 WEEKS

Generally, the typical Dianabol cycle lasts for up to 6 weeks. But it’s natural for users to wonder what they can expect in a two-week span.

Essentially, do not expect anything significant at this stage as it is too early, to say the least. But yes, D-bol does kick in in a matter of days, causing a difference in some fitness areas.

For example, a growing surge in strength and energy that builds your endurance for your grueling workouts. This surge escalates with the passage of time, allowing you to lift your progressive overload levels.

Moreover, you will notice your muscles healing at a rather faster pace than before. It is because Dbol builds more protein in the body, and protein aids in the muscle recovery process.

As for muscle gains, there is a chance of hitting the 4-6 lb. growth mark. However, that depends on your efforts and the quality of the regimen you are following.

HOW QUICKLY DOES DIANABOL WORK?

In comparison to other AAS, the anabolic steroid has a relatively short half-life, say 5 hours. However, it is impossible to say for certain how quickly you will see results.

Remember, human biology may seem easy to understand, but it is far more complex. Furthermore, there are other factors to consider, such as the intensity and duration of your workouts, how strictly you adhere to your dietary restrictions, and so on.

So yes, one cannot say for certain, but Dianabol is a fast-acting steroid. Expectedly, it begins to work in a matter of days, not weeks.

However, the improvements become visible to the naked eye after 1.5-2 weeks.

HOW MUCH DIANABOL DO I NEED FOR A CYCLE?

Depending upon your fitness goals, health condition, and fitness level, you can determine the strength of Dbol steroids. Generally, if you aim for a body makeover, 20 mg of Dianabol pills per day will do the job.

This makeover involves muscle hypertrophy and strength gains, giving you that bodybuilder aesthetic and feel. However, your standard cycle should not go beyond the 6-week mark, as Dianabol is dangerous. And you have no margin to take that risk!

 WHAT DOES DIANABOL DO TO YOUR BODY?

Dianabol synthetic hormone that puts you in an anabolic state through binding to the androgen receptors.

This anabolic response activates nitrogen retention and protein synthesis, which are two crucial processes contributing to muscle development.

Basically, these processes lead to a higher stock of protein that the body begins to make. And protein assists in the muscle regeneration process, wherein the affected muscle fibers recover and multiply after intense workouts.

This building and reproduction of muscle fibers leads to the desired muscle expansion and increased strength.

Dianabol steroids also help to improve the utilization of dietary carbs. It puts the metabolism into overdrive and gives you an overall recomposition effect.

WHAT CAN I EXPECT FROM DIANABOL CYCLE?

Dbol is powerful and so, expecting anything less from it (including side effects) is not right. Throughout your Dianabol cycle, you can anticipate a higher muscular growth that appears drastic and not average.

You will get in a position to break through your 1-rep max by the indomitable strength running in your veins. There will be a reduction in subcutaneous fat but yes, there could be fluid retention too.

DIANABOL CYCLE RESULTS

The overall Dianabol cycle results are tremendous yet equally intimidating. There is something the steroid offers in every area of your fitness from your endurance to fat loss.

But primarily, there are bigger changes for enthusiasts counting on Dianabol for mega muscle mass. Essentially, the bulking substance promotes the growth of protein that has a great say in the muscle recuperation process.

So, you can look ahead to a significant transformation in how your muscles look before and after. In simple words, you can observe:

  • A higher muscle growth (30-35lbs in a 6 weeks course)
  • Record strength that leads to dynamic workouts and athletic performance
  • Reduction of fat levels (but increase in water weight)

DIANABOL AND DECA DURABOLIN CYCLE STACKING RESULTS

This stacking option was inspired by Arnold’s bulking regimen and is said to be his trademark! As per experts, no other steroid balances Dianabol better than Deca, owing to its mild anabolic nature.

The duo works together to influence the strength and endurance level from high to exemplary. In general, the cycle lasts ten weeks, with Nandrolone (Deca) at 400 mg per week and Dianabol beginning in the third week at 10 mg daily dose and gradually increasing to 20 mg daily for the remaining six weeks.

TEST AND DIANABOL CYCLE STACKING RESULTS

Considering their potent profile, this combination does not suit amateurs and is only for the pros. Now, Dianabol is very similar to testosterone but is particularly effective in areas like serious muscle-building.

On the contrary, testosterone too, encompassesgreat muscle-building potential; it works better for leaner muscles and strength gains.

The recommended duration of the Dianabol and testosterone stack is 10 weeks. During this time, users should begin with 200 mg of testosterone (weekly) for the first week. They can then take 400 mg (weekly) for the next 4 weeks and 500 mg for the next 4. They can take a reverse gear with 200 mg (weekly) for the last week.

When it comes to Dianabol, it is critical to start with 10 mg per day in the third week. They can continue the remaining cycle with 20 mg a day.

DIANABOL AND ANADROL CYCLE STACKING RESULTS

Another powerful and fast-acting stacking option for advanced-level mass gainers is Anadrol and Dianabol. The former is essentially available in oral pills as Dianabol but is just as dangerous.

The fusion of these AAS promises incredible gains in muscle bulk and strength during and after the standard 6-week cycle. The recommended dose of Dianabol during the entire period is 30 mg a day.

As of Oxymetholone (Anadrol), a 50 mg per day dosage for 3 weeks and 75 mg per day for the remaining 3 is the best bet.

WHERE TO BUY DIANABOL STEROIDS?

To buy Dianabol in its pure and most authentic concentration, you should only trust the official website. Crazy Bulk is the top company selling best anabolic dianabol steroid alternative pills called “D-Bal”.

 

This is because it is a high demand product that is prone to dilution. Hence, trusting the official manufacturers to buy Dbol is one smart move to your bodybuilding goals!

 

Affiliate Disclosure

The links contained in this product review may result in a small commission if you opt to purchase the product recommended at no additional cost to you. This goes towards supporting our research and editorial team and please know we only recommend high-quality products.

Disclaimer

Please understand that any advice or guidelines revealed here are not even remotely a substitute for sound medical advice from a licensed healthcare provider. Make sure to consult with a professional physician before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary as the statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease.

American Pain Society
  • 8735 W. Higgins Road, Suite 300, Chicago, IL 60631
  • 847.375.4715
  • info@americanpainsociety.org
  • Facebook
  • Twitter
  • Calendar
Career Center ›
Newsroom ›
About Us ›

©2019 American Pain Society • Privacy Policy »